30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Positions

Position Company Period
Director Trevena Inc Oct. 1, 2018 -
Director Protara Therapeutics Inc Jan. 9, 2020 -
Independent Director Alaunos Therapeutics Inc Sept. 1, 2018 -
Independent Director Constellation Pharmaceuticals Inc Feb. 19, 2019 -
President, Chief Executive Officer, Director Marinus Pharmaceuticals Inc Aug. 12, 2019 -
Independent Director Esperion Therapeutics Inc Jan. 1, 2016 - March 14, 2020
Executive Chairman of the Board Marinus Pharmaceuticals Inc March 18, 2019 - Aug. 12, 2019
Independent Director Marinus Pharmaceuticals Inc Sept. 1, 2018 - March 18, 2019
Chief Operating Officer Pacira Biosciences Inc Dec. 11, 2017 - March 29, 2018
Senior Vice President - Strategy and Corporate Development Pacira Biosciences Inc July 14, 2015 - Dec. 11, 2017
Director Esperion Therapeutics Inc June 15, 2015 - Jan. 1, 2016

Scott Braunstein's trades of Marinus Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-07 2024-08-05 PlS Planned sale
11,358 -46.5%
301.10
US$3,426,242
11,358 -46.5% 301.10 US$3,426,242
2024-02-21 2024-02-16 PlS Planned sale
48,367 -4.4%
435.90
US$3,735,367
48,367 -4.4% 435.90 US$3,735,367
2023-08-08 2023-08-08 PlS Planned sale
87,771 -26.0%
98.96
US$3,345,493
87,771 -26.0% 98.96 US$3,345,493
2023-08-08 2023-08-07 PlS Planned sale
6,413 -3.8%
9.55
US$61,244
6,413 -3.8% 9.55 US$61,244
2019-12-13 2019-12-13 B Purchase
100,000 +inf%
1.25
US$125,000
100,000 +inf% 1.25 US$125,000